Sphere Medical Gears Up For EU Expansion With Proxima 4
Executive Summary
Sphere Medical is looking to increase penetration of the European market with the launch of its next-generation blood sampling device Proxima 4, which was CE-marked in September. The company said it aims to "shake up" the frequent blood measurement market.
You may also be interested in...
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
Angle Files De Novo Submission For Parsortix System In Breast Cancer
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.
Abbott Surprises Analysts With CE Mark For Freestyle Libre 3
The new continuous glucose sensor is the smallest and thinnest in the world, according to Abbott.